The effects of cortisol injection (0.2 mg/g body wt) at birth and of triglyceride feeding (20 mg/g body wt) 13 hr after birth have been studied in 16hr-old fasted newborn rats. Cortisol produced a 10% decrease in body weight and in protein concentrations of carcass, hindlimb muscle, and liver. Furthermore, cortisol induced a 60% fall in carcass lipid levels. Cortisol caused a 2-fold increase in fasting blood glucose level. This effect resulted from a stimulation of gluconeogenesis (as shown by the 2-to 3-fold rise in the rate of conversion of labeled lactate or alanine to glucose). Several factors influenced this response: 1) increase in circulating gluconeogenic substrates (lactate, pyruvate, alanine,' proline, and glutamine), 2) increase in plasma glucagon, 3) a small rise in plasma free fatty acids (FFA) arising from the catabolism of endogenous lipids, thereby providing additional energy for the hepatic conversion of gluconeogenic substrates to glucose. A concurrent decrease in.glucose utilization was unlikely since: 1) the rate of glucose disappearance after an ip glucose load was similar in fasted and cortisol-treated newborns, and 2) the rise in plasma insulin occurring after cortisol injection would ordinarily tend to increase glucose utilization.
Influence of Exogenous Cortisol and Triglyceride Feeding on Glucose Homeostasis in the Fasted
Newborn Rat 
Summary
The effects of cortisol injection (0.2 mg/g body wt) at birth and of triglyceride feeding (20 mg/g body wt) 13 hr after birth have been studied in 16hr-old fasted newborn rats. Cortisol produced a 10% decrease in body weight and in protein concentrations of carcass, hindlimb muscle, and liver. Furthermore, cortisol induced a 60% fall in carcass lipid levels. Cortisol caused a 2-fold increase in fasting blood glucose level. This effect resulted from a stimulation of gluconeogenesis (as shown by the 2-to 3-fold rise in the rate of conversion of labeled lactate or alanine to glucose). Several factors influenced this response: 1) increase in circulating gluconeogenic substrates (lactate, pyruvate, alanine,' proline, and glutamine), 2) increase in plasma glucagon, 3) a small rise in plasma free fatty acids (FFA) arising from the catabolism of endogenous lipids, thereby providing additional energy for the hepatic conversion of gluconeogenic substrates to glucose. A concurrent decrease in.glucose utilization was unlikely since: 1) the rate of glucose disappearance after an ip glucose load was similar in fasted and cortisol-treated newborns, and 2) the rise in plasma insulin occurring after cortisol injection would ordinarily tend to increase glucose utilization. Triglyceride feeding was associated with a Zfold rise in fasting blood glucose. This effect was secondary to a stimulation of gluconeogenesis by provision of free FFA, as demonstrated by the 2.5-fold increase in the conversion in vivo of labeled lactate and alanine into glucose.
In newborn rats injected with cortisol, the levels of both plasma FFA and blood ketone bodies remained far below those in suckling newborns of the same age. The combination of cortisol injection at birth with triglyceride feeding 13 hr after birth caused a Sfold increase in blood glucose levels in the ldhr-old newborn rats. The stimulating effects of cortisol on gluconeogenesis were potentiated by triglyceride feeding, as shown by the 3-to 4-fold increase in the rate of lactate or alanine conversion to glucose. However, cortisol markedly decreased the ketosis induced by triglyceride feeding and increased plasma triglycerides.
Speculation
Corticosteroids have been used in the treatment of symptomatic hypoglycemia in newborn infants. In fasted newborn rats, cortisol partially prevents hypoglycemia, but at the cost of increased protein catabolism. Moreover, cortisol has an antiketogenic effect, thus decreasing the availability of ketones as alternate fuel for brain metabolism and as Drecursor for brain l i~i d svnthesis. If such data can be extrapolated to the human newborn, the prolonged use of corticosteroids in the treatment of neonatal hypoglycemia seems less physiologic than adequate parenteral energy substrate provision in the form of intralipid and gluconeogenic precursors (lactate, amino acids, and glycerol).
Profound hypoglycemia has been shown to occur in newborn rats after a fast of 16-24 hr beginning at birth (5, 17, 19) . This hypoglycemia resulted from an inadequate rate of gluconeogenesis (19) secondary to a deficiency of gluconeogenic substrates (17, 19) and FFA (13, 19) . Newborn rats are unusual in not having fat stores available for endogenous provision of free fatty acid during fasting. They have no white adipose tissue (23) , and the small amount of lidds stored in the brown adi~ose tissue is not mobilizable durini fasting at thermoneutral tehperature (26) .
As such. thev are analorious to the Dremature or small for age.'newborns Ghich have ieficient fat stores and frequently develop neonatal hypoglycemia (4, 5) . Corticosteroid therapy has been used successfully in these and other forms of hypoglycemia (4) . The rationale behind this treatment is to use corticosteroids in pharmacologic doses for increasing amino acid mobilization from muscle, thereby stimulating gluconeogenesis, and for induction of appropriate enzyme activities. The present study was performed to analyze the effects of cortisol on glucose homeostasis in fasted newborn rats. Since triglyceride is the principal energy source in rat milk and is necessary to support the enhanced gluconeogenic rate in suckling rat (12, 14, 41) , the effect of cortisol in combination with exogenous triglyceride was also studied.
MATERIALS AND METHODS
Newborn Wistar rats were delivered by cesarean section at 18.00 hr at 21.5 days of gestation, normal gestation being 22 days. Timing of gestation was as previously described (17) . The newborns were transferred to a Humidicrib (Jouan S.A., Paris, France) in which temperature was kept constant at 37' and relative humidity at 70%. Enzymes and coenzymes were supplied by Boehringer Corp., Paris, France.
EXPERIMENTAL PROCEDURES
Cortisol Injection. A group of newborn rats was injected sc immediately after delivery with 0.2 mg/g body wt of a suspension of hydrocortisone acetate-(Acetate d'hydrocortisone, Roussel, Paris) in a volume of 50 PI, and the newborns were studied 16 hr after birth.
Triglyceride Feeding. A group of fasted newborn rats was allowed to suckle, by using a small rubber teat, 20 mg/g body wt of a triglyceride emulsion (54) 13 hr after birth and was immediately placed back in the Humidicrib for 3 hr, then studied.
Cortisol Injection and Triglyceride Feeding. Another group of newborn rats received an injection of 0.2 mg/g body wt of hydrocortisone acetate at delivery and was fed with 20 mg/g body wt of triglyceride emulsion at 13 hr and was studied at 16 hr.
Controls. Since it has been previously shown that 0.9% NaCl (w/v) feeding (20 mg/g body wt) at 13 hr did not modify any of 752 FERRE ET AL.
the measured metabolites or hormones at 16 hr (13, 14) , control rats used in the present experiments received only a sc injection of 50 pl NaCl0.9% (w/v) at delivery. Atomique, Saclay, France) 16 hr after birth and blood was sampled.30 min later as described previously (18, 19) .
Glucose Tolerance Test. Groups of fasted and cortisol-treated newborn rats were injected ip with D-glucose at a dose of 2 mg/g body wt 13 hr after birth and blood was sampled 30, 60, 120, and 180 min later. The rate of glucose disappearance (K) was calculated as follows:
and expressed in percentage per min. GI and GZ represent blood glucose concentration at time tl and tz.
Blood Sampling and Anahtic Methods. The technique for blood sampling and the biochemical methods used for metabolite, amino acid, and hormone determinations were as described previously (17) (18) (19) . Enzymatic techniques were used for the determination of lactate (38) , pyruvate (39) , glycerol (49) , alanine (50), 3-hydroxybutyrate (33) , acetoacetate (34) , and glucose (2) on blood perchloric acid filtrates. Plasma free fatty acids were determined using a radiochemical assay (25) with 63Ni as tracer (Centre de 1'Energie Atomique, Saclay, France). An automated ion-exchange chromatographic technique on Beckman 120 C amino acid analyzer with lithium buffer system was used for the determination of individual amino acids on blood sulfosalicylic filtrates (27) . Triglycerides in plasma or tissues were extracted by the method of Folch et al. (15) and their glycerol content was determined after ethanolic-alkaline hydrolysis (30) . In some experiments, hindlirnb muscles, liver, interscapular brown adipose tissue, and carcass (i.e., whole body minus viscera) were obtained and frozen in liquid nitrogen immediately after blood sampling. Liver, muscle, and carcass glycogen were determined by using the enzymatic technique with amyloglucosidase (EC 3.2.1.33) as described by Roehrig and Allred (44) . Lipids in the carcass were measured as described by Folch et al. (15) . Proteins were precipitated with 10% (w/v) trichloracetic acid. The precipitate thus obtained was dissolved in 1 N NaOH and an aliquot was analyzed for its protein content (20) .
Insulin and glucagon were determined by radioimmunoassays (1, 28) . Glucagon was assayed using antibody 30K (supplied by Dr. R. H. Unger, Dallas, TX) and purified pork glucagon as standard (Novo Industry SA, Copenhagen, Denmark) and tracer (Centre National de la Transfusion Sanguine, Paris, France). Insulin was assayed using a guinea pig antibody reacting poorly with proinsulin, human insulin as tracer (Centre National de la Transfusion Sanguine) and purified rat insulin as standard (Novo Industry SA).
Measurement of gluconeogenic rate in vivo was performed as described previously (12, 18, 19) using lactate space equal to the total body water, i.e., 80 mg/100 g body wt, and glucose and alanine spaces equal to the extracellular water, Le., 60 m1/100 g body wt. The validity of this method has been discussed previously (18, 19) . The separation of labeled glucose and charged compounds was performed using ion-exchange resins as described previously (1 2).
Results are expressed as mean k SEM. Statistical analyses were performed using the Student unpaired t-test, to establish the significance of changes between control and experimental groups.
RESULTS

EFFECTS OF CORTISOL ON BODY WEIGHT AND ON COMPOSITION OF CARCASS, LIVER, SKELETAL MUSCLE, AND BROWN ADIPOSE TISSUE OF FASTED NEWBORN RATS
A fast of 16 hr in a thermoneutral environment produced a 10% decrease in body weight of newborn rats (Table 1 ). This was associated with a marked fall in carcass, skeletal muscle, and liver glycogen levels and with a 10% decrease in carcass and skeletal muscle protein concentrations ( Table 1 ). The liver proteins were not decreased by fasting. The concentrations of lipids in the carcass and of triglycerides in the brown adipose tissue were not decreased by fasting in a thermoneutral environment. By contrast, fasting induced a 50% fall in liver triglyceride levels (Table 1) .
Cortisol injection at birth caused a further decrease in body weight of fasted newborn rats (table 1) . When compared with fasted newborns, the fasted pups injected with cortisol showed a 10% decrease in carcass, skeletal muscle, and liver protein concentrations and a 60% fall in carcass lipid levels (table 1) . Cortisol injection caused a significant increase in liver triglyceride concentration in fasted newborns (Table 1) .
EFFECTS OF CORTISOL, TRIGLYCERIDE FEEDING, AND CORTISOL IN COMBINATION WITH TRIGLYCERIDE FEEDING ON CIRCULATING BLOOD SUBSTRATES AND HORMONES
Cortisol injection at birth produced a 2-fold increase in blood glucose level, compared with fasted controls (Table 2 ). This was associated with a rise in both plasma insulin and glucagon (Table  2) . Concurrently, cortisol administration was associated with a marked increase in gluconeogenic substrates as compared to 16-hr-old fasted newborn rats. An increase in lactate, pyruvate (Table   2) , glutamine, proline, and alanine as well as in tyrosine, citrulline, and ornithiie (Table 3 ) was observed. Cortisol also induced a 2-fold increase in plasma FFA and blood ketone bodies ( Table 2) .
As previously reported (13, 14) , triglyceride feeding alone produced a 2-fold increase in blood glucose (Table 2) and was associated with a 7-fold increase of blood ketones, a 3-fold increzic of FFA, and a modest but significant rise in triglycerides, glycerol, lactate, and pyruvate. Plasma insulin increased after triglyceride feeding but glucagon remained unchanged (Table 2 ). Significant increases in blood glutamine, proline, alanine, and isoleucine were also observed in triglyceride-fed newborn rats (Table 3) .
A combination of cortisol injection at birth and triglyceride feeding 13 hr after birth resulted in a 3-fold increase in blood glucose level in 16-hr-old newborn rats ( Table 2 ). The levels of gluconeogenic substrates and of insulin and glucagon were the same in newborns injected with cortisol alone and those injected Table 2 . Effects of cortisol, ~riglyceride feeding, and cortisol plus trzglyceride feeding on circulating substrates (millimoles per liter) ' P < 0.05 when compared with triglyceride fed. P < 0.05 when compared with cortisol.
' P < 0.05 when compared with the fasted controls.
Q
with cortisol and fed with triglycerides (Tables 2 and 3 ). Plasma . Semilogarithmic graph of blood glucose concentration after ip injection of 2 mg glucose/g body wt in fasted and cortisol-injected newborn rats. Fasted newborn rats were injected sc with 0.9% NaCl or with cortisol (0.2 mg/g body wt) immediately after birth, and injected with glucose 13 hr after birth. W, fasted controls; 0---0, cortisol treated. A total of 60 pups were used for each glucose tolerance test. Each point is the mean f SEM of a group of 12 different newborns.
higher in cortisol-treated group than in the fasted group, there was n o alteration in glucose tolerance demonstrable by this technique in newborns injected with cortisol. The calculated rate of glucose disappearance was (in percentage per min): 1.31 in fasted controls and 1.35 in cortisol-injected newborns. Using the same glucose tolerance test, it was previously observed that triglyceride feeding alone did not modify the rate of glucose disappearance: 1.4%/min in fasted controls and 1.5%/min in triglyceride-fed newborns (14) .
EFFECTS OF CORTISOL AND CORTISOL PLUS TRIGLYCERIDE FEEDING ON GLUCONEOGENESIS
Cortisol injection at birth increased the rate of gluconeogenesis from lactate and alanine 2-to 3-fold by 16 h r (Table 4) . Triglyceride feeding at 13 h r increased gluconeogenesis from lactate and alanine 2.5-fold. The combination of cortisol injection at birth and triglyceride feeding at 13 h r increased by 3-to 4-fold the rate of gluconeogenesis from lactate and alanine, when compared to fasted controls. However, only the rate with lactate as substrate was significantly greater with combined treatment than with cortisol alone.
These increases resulted from both a n increased pool size of precursor and a n increased conversion of labeled substrate into glucose. The latter effect may be linked in part to the rise in 754 FERRE plasma glucagon (Table 2) , although the levels in fasted controls are already markedly elevated.
The specific radioactivity of precursor at the time of samplimg was, respectively: 10, 15, and 20% lower in cortisol, triglyceridefed, and cortisol plus triglyceride-fed newborns than in fasted newborns. This caused a small underestimation of the effect of cortisol, triglyceride feeding, and cortisol plus triglyceride feeding in those experiments.
DISCUSSION
The aims of the present work were to use exogenous cortisol in pharmacologic doses as a mean of protecting the newborn rat from developing hypoglycemia when fasted at birth, and to examine the mechanisms of these effects. It is recognized that this approach does not necessarily provide the evidence that the postnatal increase in plasma corticosterone (8) plays a physiologic role in neonatal metabolic adaptations.
The hypoglycemia which develops in fasted newborn rats is partially reversed by giving cortisol alone but is better prevented by the combination of cortisol and oral triglycerides ( Table 2) . These fmdings are paralleled by previous observations showing that oral triglyceride or exogenous gluconeogenic substrate injection individually, only partially reversed neonatal fasting hypoglycemia, but that the combination of oral triglyceride with exogenous gluconeogenic substrate injection completely reversed this hypoglycemia (13, 14) , with reference to normally suckling pups (12, 19, 41) .
These data clearly show that lack of gluconeogenic substrates is not the only factor limiting the activity of gluconeogenesis in fasted newborn rats. Since the effect of increased gluconeogenic substrate on glycemia is markedly potentiated by fat feeding, both FFA availability and hepatic fatty acid oxidation are essential to sustain a high rate of hepatic gluconeogenesis.
EFFECTS OF CORTISOL
Two mechanisms may explain the rise in blood glucose after cortisol injection in fasted newborn rats. 1) A decrease in glucose utilization is possible, secondary to the rise in plasma FFA and ketone bodies (42) or to a direct effect of cortisol on glucose uptake in several tissues (36) . 2) A stimulation of gluconeogenesis is probable, secondary to increased provision of gluconeogenic substrates and of ATP, NADH, and acetyl-CoA, via increased plasma FFA and/or to an increase of hepatic enzyme activities. Several limes of evidence render unlikely that a decreased utilization of glucose is responsible for the rise in blood glucose after cortisol injection: a) the rate of glucose disappearance after an ip glucose load is similar in fasted and cortisol-injected newborn rats, b) the glucose turnover rate, measured using [3-3H] glucose, is increased after cortisol injection in fasted newborn rats (FerrC, Pegorier, and Girard, unpublished data), and c) the rise of plasma insulin occurring after cortisol injection would tend to increase rather than decrease glucose utilization.
The present data suggest that cortisol increases blood glucose levels in fasted newborn rats by stimulating gluconeogenesis, through several independent though interacting mechanisms: 1) the increase in circulating gluconeogenic substrates; 2) the increase in plasma glucagon; 3) the rise in plasma FFA. These factors will be considered and discussed successively.
We have previously reported that cortisol injection at delivery increased blood lactate and caused a generalized and marked hyperaminoacidemia in 4-hr-old fasted newborn rats (18) . The present data show that these effects of cortisol are still observed 16 hr after birth, but are of smaller magnitude than at 4 hr, and affect only alanine, glutamine, and proline among gluconeogenic amino acids. A likely explanation is that the effects of cortisol are blunted by the rise of plasma amino acids which occurs spontaneously between 6 and 16 hr in fasted newborn rats (19) . The increase in blood amino acids produced by cortisol in fasted newborn rats probably results from a stimulation of protein breakdown and/or an inhibition of protein synthesis in peripheral tissues (35) , since the weight and protein content of carcass and muscle are decreased in fasted newborn rats injected with cortisol ( Table 1 ). The salutory effect of cortisol on blood glucose levels was obtained at the cost of increased protein utilization, which could result in muscle wasting; this is undesirable for an organism in which continuation of growth is the first priority. The rise in blood lactate observed after corticosteroid injection to fasted newborn rats, or to adult rats treated with phloridzin (31), probably results from a stimulation of lactate production by peripheral tissue greater than the stimulation of hepatic uptake for gluconeogenesis. Lactate could be synthetized from pyruvate, derived from amino acid catabolism or from an increased glycolysis secondarily to the rise in blood glucose and plasma insulin ( Table   -I\ 
LI'
Cortisol stimulates glucagon secretion in newborn rats even in presence of hyperglycemia (Ref. 18 and the present study). This effect has also been observed in the adult man (32, 52) and rat (3 1). Since exogenous glucagon increases the rate of gluconeogenic substrate conversion to glucose in newborn rats (18, 48) , the enhanced release of gluckon produced by cortisol probably contributes to its stimulatorv effects on neonatal ~luconeoeenesis.
Cortisol increases plaska FFA in fasted neiborn rat: and these FFA appear to arise from the catabolism of lipids of the carcass. Since FFA availability is essential to sustain an active gluconeogenic rate in newborn rats (13, 14) , a part of the stimulatory effects of cortisol on gluconeogenesis may be secondary to this peripheral lipolytic action.
In adults, glucocorticoids act on hepatic gluconeogenesis by increasing several key gluconeogenic enzymes, i.e., transaminases, pyruvate carboxylase, phosphoenolpymvate carboxykinase, fmctose disphosphatase, glucose-6-phosphatase (reviewed in Refs. 9, 11). However, it is unlikely that these changes entirely account for the effectiveness of the corticosteroids, since gluconeogenic substrate flow to the liver appears to be the dominant rate-limiting factor (7, 16) . In the present study, such a direct effect on liver enzyme activities has not been investigated. In neonatal rats, cortisol has been shown to increase the activity of alanine aminotransferase (47), but it remained without effect on the activities of pyruvate carboxylase, phosphoenolpymvate carboxykinase,' fructose diphosphatase and glucose-6-phosphatase (21, 53) . It is unlikely that a direct effect of cortisol on hepatic alanine transaminase can play an important role in the stimulation of gluconeogenesis observed in the present study, since the effect of this hormone is much more marked with lactate as substrate than with alanine as substrate.
EFFECTS OF TRIGLYCERIDE FEEDING
The mechanisms involved in the rise of blood glucose induced by triglyceride feeding alone have been discussedpreviously (13, 14) . The rise in blood glucose induced by fat feeding was not secondary to a decreased glucose utilization, since the rate of glucose disappearance after ip glucose injection was similar in fasted (1.4% min-') and fat-fed (1.5% min-') newborns (14) . Several limes of evidence suggest that fat feeding was associated with stimulation of gluconeogenesis by provision of fatty acids: 1) the rise in blood glucose after fat feeding was totally suppressed by an inhibitor of gluconeogenesis (3-mercaptopicolinate); 2) a 3-fold increase in the conversion of labeled lactate or alanine into glucose was observed in vivo after fat feeding, as also reported here in Table 4 ; and 3) concurrent inhibition of fatty acid oxidation by sodium Cpentenoate abolished the glycemic rise related to fat feeding (14) . Furthermore, inhibition of fatty acid oxidation by sodium 4-pentenoate in suckling newborn rats markedly inhibited gluconeogenesis from lactate and induced a profound hypoglycemia (41) . This suggests that adequate hepatic fatty acid oxidation is essential to supply the energy required to sustain a high rate of gluconeogenesis. Although cortisol alone increases the blood glucose and ketone bodies and the plasma FFA in fasted newborn rats, the a b s o l u t e levels of these substrates remain far below those measured in suckling newborn rats of the same age (12, 19, 41) . Fat feeding was given in combination with cortisol injection to provide these newborns with sufficient fat-derived substrates exogenously.
Triglyceride feeding and cortisol show additive effects on blood glucose levels of fasted newborn r a t s (Table 2) . However, the magnitude of the rise in blood glucose is less marked than in previous experiments in which the effects of triglyceride feeding were associated with injection of exogenous gluconeogenic substrates (13, 14) . A likely explanation is that cortisol alone not only increases gluconeogenic substrate availability, but also stimulates the mobilization of lipids from the carcass (Table l) , thus providing some FFA to the liver for sustaining the energy-requiring conversion of substrates to glucose. Accordingly, the potentiating effect of exogenous triglycerides is somewhat lessened.
In newborn rats injected with cortisol and fed with triglyceride, the simultaneous decrease in blood ketone bodies and increase in plasma triglycerides suggest that cortisol decreases hepatic fatty acid oxidation rather than it increases ketone body utilization. In adult rats, corticosteroids have been previously shown to prevent the increase in ketone bodies caused by cold exposure (45) , fasting (10, 46) , and phloridzin-treatment (31). They have a similar effect in starved adult man (22) and in children with k e t o t i c hypoglycemia (3, 37) . Glucocorticoids have been reported to increase plasma triglycerides in adult rats (43) and this has been interpretated as being secondary to the rise in plasma insulin (6), this hormone stimulating hepatic lipogenesis. However, corticosteroids stimulate the release of triglycerides by the isolated perfused rat liver (29) and suckling newborn rats which show a high rate of hepatic ketogenesis have plasma insulin levels higher (12, 19, 41) than those measured in newborn rats injected with cortisol and fed with triglycerides. This suggests that cortisol could act directly on the liver to channel the flow of FFA towards esterification and thus to decrease fatty acid oxidation and ketogenesis.
The antiketogenic effect of cortisol is particularly undesirable during the neonatal period since the newborn brain m e t a b o l i z e s ketone bodies for energy production, and thus partially reduces glucose requirement for cerebral metabolism (51) . Furthermore, it has been recently demonstrated that ketone bodies are better precursors than glucose for lipid synthesis in developing brain (40) . . .
Information gathered from this study of the influence of exogenous cortisol and lipids on glucose homeostasis of the newborn rat may not be directly extrapolated to o t h e r mammals, and particularly the human, because of features peculiar to this species: very low body fat c o n t e n t and a high basal metabolic rate. However, such s t u d i e s may help to understand the mechanisms responsible for the profound hypoglycemia occurring in low birth weight infants which have a low body fat c o n t e n t and an impairment of gluconeogenesis (24) .
